| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/14/2006 | US20060205038 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 09/14/2006 | US20060205034 Expression vector comprising nucleotide sequences coding membrane protein for identifying modulators for prevention and treatment of lung, gastrointestinal and cell proliferative disorders |
| 09/14/2006 | US20060205021 Mammalian IAP gene family, primers, probes and detection methods |
| 09/14/2006 | US20060205018 Polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides; use in therapy |
| 09/14/2006 | US20060205008 Inhibiting association with survivin in presence of caspase; stimulates neoplastic cell death; treatment of liver disorders |
| 09/14/2006 | US20060204998 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon |
| 09/14/2006 | US20060204986 Ligand bound viral envelope protein for use in inducing anti-human immunodeficiency virus antibodies; treatment and prevention of viral disease |
| 09/14/2006 | US20060204966 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor |
| 09/14/2006 | US20060204958 Methods for diagnosing htlv-i-mediated diseases |
| 09/14/2006 | US20060204957 Mta1s, a steriod hormone receptor corepressor |
| 09/14/2006 | US20060204507 Method for generating an immune response and reagents therefor |
| 09/14/2006 | US20060204506 Anti-mesothelin antibodies |
| 09/14/2006 | US20060204503 Treatment of cancer using antibodies to polypeptides differentially expressed in human lung tumors |
| 09/14/2006 | US20060204499 Tumour necrosis factor binding ligands |
| 09/14/2006 | US20060204498 Novel antagonists of cxcr3-binding cxc chemokines |
| 09/14/2006 | US20060204497 Customization of cancer therapy by adminstering modifying antibodies from antigens expressed from cancerous tissue which are cytotoxic to cancer cells while non-toxic to non-cancerous cells; monoclonal antibody antigen binding fragment having identifying characteristics by cloning deposits |
| 09/14/2006 | US20060204496 Agonist antibody against heteroreceptor |
| 09/14/2006 | US20060204494 Methionine sulfoxide antibodies |
| 09/14/2006 | US20060204493 Heteromultimeric molecules |
| 09/14/2006 | US20060204492 Compositions and methods for producing enhanced antibodies |
| 09/14/2006 | CA2601550A1 Method of in-vitro diagnosis of alzheimer's disease by means of a monoclonal antibody |
| 09/14/2006 | CA2600929A1 Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues |
| 09/14/2006 | CA2600836A1 Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent |
| 09/14/2006 | CA2600608A1 Composition comprising human igg2 antibody and chelating agent |
| 09/14/2006 | CA2600601A1 Anti-m-csf antibody compositions having reduced levels of endotoxin |
| 09/14/2006 | CA2600588A1 Anti-madcam antibody compositions |
| 09/14/2006 | CA2600434A1 Anti-ctla-4 antibody compositions |
| 09/14/2006 | CA2600375A1 Tyrosine kinase inhibitor compositions and methods for manufacturing and using them in the treatment of disease |
| 09/14/2006 | CA2599792A1 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies |
| 09/14/2006 | CA2599577A1 Nucleic acids and proteins and methods for making and using them |
| 09/14/2006 | CA2599465A1 Antibody based rodenticide |
| 09/14/2006 | CA2597485A1 Methods and compositions for modulating tweak and fn14 activity |
| 09/14/2006 | CA2597255A1 Natural ligand of g protein coupled receptor rcc356 and uses thereof |
| 09/13/2006 | EP1700916A1 Novel centromeric protein shugoshin |
| 09/13/2006 | EP1700868A2 A method for removing an antibody from blood or plasma |
| 09/13/2006 | EP1700867A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/13/2006 | EP1700866A2 Cerebral organic anion transporter and its gene |
| 09/13/2006 | EP1700606A1 Therapies for chronic renal failure using one or more integrin antagonists |
| 09/13/2006 | EP1700122A2 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics |
| 09/13/2006 | EP1700121A2 Agonist anti-trkc antibodies and methods using same |
| 09/13/2006 | EP1700120A2 Marker for neuromyelitis optica |
| 09/13/2006 | EP1700119A1 Beta-lactamase cd4+ t-cell epitopes |
| 09/13/2006 | EP1699925A1 Il-23 and its receptor; related reagents and methods |
| 09/13/2006 | EP1699827A1 Antibody inhibiting uracil-dna-glycosylase and uses thereof for decontaminating nucleic acid amplification reactions |
| 09/13/2006 | EP1699826A1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| 09/13/2006 | EP1699825A2 Methods for identifying functional antibodies |
| 09/13/2006 | EP1699824A2 Ztnf 12, a tumor necrosis factor |
| 09/13/2006 | EP1699823A2 Use of il-18 binding protein in inflammations |
| 09/13/2006 | EP1699822A2 Il-7 fusion proteins with antibody portions, their preparation and their use |
| 09/13/2006 | EP1699487A2 Novel anti-dc-sign antibodies |
| 09/13/2006 | EP1699486A2 Anti-human lymphotoxin alpha antibodies, compositions, methods and uses |
| 09/13/2006 | EP1699485A2 Anti-hydroxylase antibodies and uses thereof |
| 09/13/2006 | EP1699484A2 Humanized antibodies against vascular endothelial growth factor |
| 09/13/2006 | EP1535046A4 Screening antibodies using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 09/13/2006 | EP1535045A4 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 09/13/2006 | EP1499887A4 Universal libraries for immunoglobulins |
| 09/13/2006 | EP1339840B1 Schizophrenia-related voltage-gated ion channel gene and protein |
| 09/13/2006 | EP1312677B1 Nucleic acids encoding lettuce big-vein virus proteins and utilization thereof |
| 09/13/2006 | EP1302477B1 Peptide fructose and complex thereof with binding protein |
| 09/13/2006 | EP1280828B1 Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses |
| 09/13/2006 | EP1224288B1 Processed human chemokine phc-1 |
| 09/13/2006 | EP1163272B1 Antibodies specific for cyp1b1 |
| 09/13/2006 | EP1095062B1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
| 09/13/2006 | EP0811065B1 Antagonists of interleukin-15 |
| 09/13/2006 | EP0755446B1 Cardiotrophin and uses therefor |
| 09/13/2006 | CN1833030A Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| 09/13/2006 | CN1833020A Pro104 antibody compositions and methods of use |
| 09/13/2006 | CN1832969A Etherified carbamate functional copolymers of isobutylene type monomers, and their use in curable compositions |
| 09/13/2006 | CN1832965A Endothelial cell specific antibodies and uses thereof |
| 09/13/2006 | CN1832964A Method of detecting probnp with a monoclonal antibody binding to the amino acids 41-46 |
| 09/13/2006 | CN1832756A Method of altering the binding specificity of proteins by oxidation-reduction reactions |
| 09/13/2006 | CN1832752A Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques |
| 09/13/2006 | CN1831121A Method for structuring hybridoma cell system for anti-human monoclonal antibody of hepatitis B virus and its application |
| 09/13/2006 | CN1831120A Hybridoma cell strain, and anti-human heparin enzyme monoclonal anti-body produced by it |
| 09/13/2006 | CN1831009A Prawn white-spots syndrom virus (WSSV) membrane protein and its antibody |
| 09/13/2006 | CN1275041C Prognostic indicator |
| 09/13/2006 | CN1274817C Anti prourokinase monoclonal antibody hybrid oma cell line and its application |
| 09/13/2006 | CN1274235C Anti-dental caries chewing gum and preparation |
| 09/12/2006 | US7105652 Human tumor suppressor gene |
| 09/12/2006 | US7105651 Nucleotide sequences coding polypeptide for use in the treatment of cancer, inflammation and infection; for use as pesticide and antibiotic |
| 09/12/2006 | US7105649 Gene and amplification with polynucleotides having amino acid sequence |
| 09/12/2006 | US7105644 Secreted protein HHTLF25 antibodies |
| 09/12/2006 | US7105643 Antibodies for immunoassay of specific pyrolysis products anhydroecgonine methyl ester and ecgonidine; hybridomas; immunogens to evoke immune response in animals exposed to the metabolites; animal models |
| 09/12/2006 | US7105642 Monoclonal antibodies specific for phosphorylated estrogen receptor alpha (Ser118) and uses thereof |
| 09/12/2006 | US7105641 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents |
| 09/12/2006 | US7105640 Anti-pro792 antibodies |
| 09/12/2006 | US7105639 Anti-PRO 4405 antibodies |
| 09/12/2006 | US7105638 A fusion polypeptide with a cysteine-free hinge region and secondary structure that exposes the cleavage site to a selected endopeptidase |
| 09/12/2006 | US7105488 inhibiting a target G protein-coupled receptor (GPCR) by contacting a cell that expresses GPCR with an isolated GPCR-modulating peptide; inhibits a biological activity of GPCR by disrupting the structure; antitumor, prevents binding of a virus and subsequent infection |
| 09/12/2006 | US7105484 GDNF receptorα |
| 09/12/2006 | US7105348 Obtaining a large cloned genomic fragment; using bacterial homologous recombination to genetically modify to create a large targeting vector for use in eukaryotic cells (LTVEC); introducing LTVEC into eukaryotic cells; quantitative assay |
| 09/12/2006 | US7105333 Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon |
| 09/12/2006 | US7105330 Immunoglobulin for detection and isolation of preferential glycosidase; tumor diagnosis and antitumor agents |
| 09/12/2006 | US7105324 Nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use |
| 09/12/2006 | US7105317 Immunogenic compositions comprising vrg-gene products from Bordetella extracts |
| 09/12/2006 | US7105316 Neisseria lactoferrin binding protein |
| 09/12/2006 | US7105297 Evolution of biocatalytic activity in cell; obtain nucleotide sequences, recombine sequences in gene, transform into cell, monitor cell for novel biocatalytic activity |
| 09/12/2006 | US7105291 Detecting sensitivity to kidney disease |
| 09/12/2006 | US7105166 Soluble CTLA4 mutant molecules and uses thereof |
| 09/12/2006 | US7105163 Mite protein |